Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

Cited by (332)

Items 201–300 of 332

1. Functional and Structural Mimicry of Cellular Protein Kinase A Anchoring Proteins by a Viral Oncoprotein
   Cason R. King, Michael J. Cohen, Gregory J. Fonseca, Brennan S. Dirk, Jimmy Dimitrios Dikeakos, Joe S. Mymryk · 2016 · PLoS Pathogens
2. Negative regulation of miR‐1275 by H3K27me3 is critical for glial induction of glioblastoma cells
   Jialuo Mai, Jiayu Gu, Ying Liu, Xincheng Liu, Ke Sai, Zhijie Chen, Wanjun Lu, Xiaozhi Taro Yang, Jingyi Wang, Cui Guo et al. · 2019 · Molecular Oncology
3. Redifferentiation therapeutic strategies in cancer
   Mariano Bizzarri, Alessandro Giuliani, Alessandra Cucina, Mirko Minini · 2020 · Drug Discovery Today
4. MicroRNA‑199a/b‑5p inhibits endometrial cancer cell metastasis and invasion by targeting FAM83B in the epithelial‑to‑mesenchymal transition signaling pathway
   Hanzhen Xiong, Na Wang, Hui Chen, Minfen Zhang, Qiongyan Lin · 2021 · Molecular Medicine Reports
5. Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis
   Ali Niapour, Naisana Seyedasli · 2022 · Naunyn-Schmiedeberg s Archives of Pharmacology
6. The 8‐oxoguanine DNA glycosylase‐synaptotagmin 7 pathway increases extracellular vesicle release and promotes tumour metastasis during oxidative stress
   Ying Ma, Jiarong Guo, Haipeng Rao, Jingyu Xin, Xinyi Song, Rui Liu, Shan Shao, Jiajia Hou, Liyu Kong, Zhigang Hu et al. · 2024 · Journal of Extracellular Vesicles
7. Ginsenoside CK inhibits EMT and overcomes oxaliplatin resistance in gastric cancer by targeting the PI3K/Akt pathway
   Li Zhang, Xiao-Lan Zhao, Zhang-Jing Cao, Ke-Di Li, Li-Yue Xu, Fei Tang, Jingnan Zhang, Cheng Peng, Hui Ao · 2025 · Phytomedicine
8. GNAS shifts metabolism in pancreatic cancer
   Pablo E. Hollstein, Reuben J. Shaw · 2018 · Nature Cell Biology
9. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia
   Pavan Kumar Dhanyamraju, Soumya Iyer, Gayle M. Smink, Yevgeniya Bamme, Preeti Bhadauria, Jonathon Lee Payne, Elanora Dovat, Morgann Klink, Yali Ding · 2020 · International Journal of Molecular Sciences
10. Subconfluent ARPE-19 Cells Display Mesenchymal Cell-State Characteristics and Behave like Fibroblasts, Rather Than Epithelial Cells, in Experimental HCMV Infection Studies
    Preethi Golconda, Mariana Andrade-Medina, Adam Oberstein · 2023 · Viruses
11. PHF2 regulates genome topology and DNA replication in neural stem cells via cohesin
    Jia Feng, You Heng Chuah, Yajing Liang, Nadia Omega Cipta, Yingying Zeng, Tushar Warrier, Gamal Ahmed Elfar, Jeehyun Yoon, Oleg V. Grinchuk, Emmy Xue Yun Tay et al. · 2024 · Nucleic Acids Research
12. Targeting oncogene-induced cellular plasticity for tumor therapy
    Bin Li, Ling‐Ling Zheng, Jianhua Yang, Liang‐Hu Qu · 2024 · Advanced Biotechnology
13. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer
    Tony Pang, Zhihong Xu, Alpha Raj Mekapogu, Srinivasa P. Pothula, Therese M. Becker, Susan Corley, Marc Ronald Wilkins, David Goldstein, Romano C. Pirola, Jeremy S. Wilson et al. · 2021 · Cancers
14. A Cre-dependent reporter mouse for quantitative real-time imaging of protein kinase A activity dynamics
    Elizabeth I. Tilden, Aditi Maduskar, Anna Oldenborg, Bernardo Luis Sabatini, Yao Chen · 2024 · Scientific Reports
15. Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase
    Jichun Yang, Jing Ma, Yu Xiong, Yanlin Wang, Kaiyue Jin, Wenjun Xia, Qing Chen, Jianbo Huang, Jin Zhang, Nan Jiang et al. · 2018 · Journal of Cellular Physiology
16. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
    Aistė Gulla, Urte Andriusaityte, Gabrielius Zdanys, Elena Babonaite, Kęstutis Strupas, Helena M. Kelly · 2022 · Medicina
17. Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
    Ahmad Najem, Jasper Wouters, Mohammad Krayem, Florian Rambow, Malak Sabbah, François Salès, Ahmad Hussein Awada, Stein Aerts, Fabrice Journé, Jean‐Christophe Marine et al. · 2021 · Frontiers in Oncology
18. Many faces and functions of GSKIP: a temporospatial regulation view
    Nian-Siou Wu, Yifan Lin, I. Chu Ma, Huey-Jiun Ko, Yi‐Ren Hong · 2022 · Cellular Signalling
19. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer
    Run-Chang Wang, Dongyang Gao, Chaohu Chen, Guangrui Fan, Hui Cheng, Yan Tao, Jianzhong Lu, Junqiang Tian, Yuhan Wang, Zhiping Wang · 2022 · Clinical & Translational Oncology
20. The role of stromal cells in epithelial–mesenchymal plasticity and its therapeutic potential
    Juanjing Wang, Junmei Peng, Yonglin Chen, Moussa Ide Nasser, Hui Qin · 2024 · Discover Oncology
21. Forskolin exerts anticancer roles in non-Hodgkin’s lymphomas via regulating Axin/β-catenin signaling pathway
    Hailei Wang, Chunyan Lou, Na Ma · 2019 · Cancer Management and Research
22. KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma
    Tyler S. McCann, Janet K. Parrish, Joseph Chia Yu Hsieh, Marybeth Sechler, Lays Martin Sobral, Chelsea Self, Kenneth L. Jones, Andrew E. Goodspeed, James C. Costello, Paul Jedlicka · 2020 · Oncotarget
23. Mesenchymal-to-Epithelial Transitions in Development and Cancer
    John-Poul Ng-Blichfeldt, Katja Röper · 2020 · Methods in molecular biology
24. Dlk1 regulates quiescence in calcitonin receptor-mutant muscle stem cells
    Lidan Zhang, Manami Kubota, Ayasa Nakamura, Takayuki Kaji, Shigeto Seno, Akiyoshi Uezumi, Ditte Caroline Andersen, Charlotte Harken Jensen, So‐ichiro Fukada · 2020 · Stem Cells
25. Altered Expression of Candidate Genes in Mayer–Rokitansky–Küster–Hauser Syndrome May Influence Vaginal Keratinocytes Biology: A Focus on Protein Kinase X
    Paola Pontecorvi, Francesca Megiorni, Simona Camero, Simona Ceccarelli, Laura Bernardini, Anna Capalbo, Eleni Anastasiadou, Giulia Gerini, Elena Messina, Giorgia Perniola et al. · 2021 · Biology
26. The Molecular Basis of Histone Demethylation
    John R. Horton, Molly Gale, Qin Yan, Xiaodong Cheng · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
27. Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition
    Isabel O’Connell, Anushka Dongre · 2023 · Molecular Diagnosis & Therapy
28. Nanotherapeutic strategies exploiting biological traits of cancer stem cells
    Hongyu Wang, Wenjing Zhang, Yun Sun, Xican Xu, Xiaoyang Chen, Kexu Zhao, Zhao Yang, Huiyu Liu · 2025 · Bioactive Materials
29. High throughput-screening of native herbal compounds identifies taccaoside A as a cytotoxic compound that mediates RAS signaling in cancer stem cells
    Dong Yang, Zhi Dai, Peifeng Zhu, Wang Gan, Bin Sun, Shirong Li, Junjun Hao, Yifen Wang, Yaping Liu, Shuaishuai Yu et al. · 2022 · Phytomedicine
30. How studies in developmental epithelial-mesenchymal transition and mesenchymal-epithelial transition inspired new research paradigms in biomedicine
    Jean Paul Thiery, Guojun Sheng, Xiaodong Shu, Raymond Bruce Runyan · 2024 · Development
31. Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase
    Jie Lei, Yujia Pan, Rui Gao, Bin He, Zifeng Wang, Xinxing Lei, Zijian Zhang, Na Yang, Min Yan · 2023 · Journal of Translational Medicine
32. Clinical implications of epithelial-to-mesenchymal transition in cancers which potentially spread to peritoneum
    Ludovico Carbone, Giosuè Giordano Incognito, Dalila Incognito, Lorenzo Nibid, Giuseppe Caruso, Massimiliano Berretta, Chiara Taffon, Marco Antonio Palumbo, Giuseppe Perrone, Franco Roviello et al. · 2025 · Clinical & Translational Oncology
33. ECM Mechanics Control Jamming-to-Unjamming Transition of Cancer Cells
    Claudia Tanja Mierke · 2025 · Cells
34. EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications
    Ioannis A. Voutsadakis · 2023 · Current Issues in Molecular Biology
35. Transcriptomic analysis identifies enrichment of cAMP/PKA/CREB signaling in invasive lobular breast cancer
    Susrutha Puthanmadhom Narayanan, Abdalla M. Wedn, Osama Shiraz Shah, Jian Chen, Daniel D. Brown, Priscilla F. McAuliffe, Steffi Oesterreich, Adrian V. Lee · 2024 · Breast Cancer Research
36. Transcompp : understanding phenotypic plasticity by estimating Markov transition rates for cell state transitions
    Narendra Suhas Jagannathan, Mario Octavianus Ihsan, Xiao Xuan Kin, Roy E. Welsch, Marie‐Véronique Clement, Lisa Tucker‐Kellogg · 2020 · Bioinformatics
37. Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition
    Alice H. L. Bong, Gregory Raymond Monteith · 2017 · The International Journal of Biochemistry & Cell Biology
38. Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties
    Junnian Zhou, Tzu-Chen Rautio, Chang Liu, Xiaoyu Xu, Dongqing Wang, Yong Guo, John Eriksson, Hongbo Zhang · 2020 · Pharmaceutics
39. Treatment of Full-Thickness Skin Wounds with Blood-Derived CD34 + Precursor Cells Enhances Healing with Hair Follicle Regeneration
    Shao-wei Li, Min Hu, Hermann Peter Lorenz · 2019 · Advances in Wound Care
40. The role of liquid-liquid phase separation in defining cancer EMT
    Yuan Li, Yuqing Feng, Songmei Geng, Feng Xu, Hui Jun Guo · 2024 · Life Sciences
41. Forskolin sensitizes pancreatic cancer cells to gemcitabine via Stat3 and Erk1/2 inhibition
    Michela Illiano, Luigi Sapio, Ilaria Caiafa, Emilio Chiosi, Annamaria Spina, Silvio Naviglio, † These two authors equally contributed to this work. · 2017 · AIMS molecular science
42. Tadalafil Reverses the Effect of Three-Dimensional Cell Culture System on Stem Cell Features in A549 and SK-MES-1
    Mengqing Li, Yajie Liu, Weifei Zhang, Chen Li, Yu Ting Zhu, Shubin Wang · 2021 · DNA and Cell Biology
43. Modulating cell differentiation in cancer models
    Paola Fulghieri, Lucia Anna Stivala, Virginie Sottile · 2021 · Biochemical Society Transactions
44. Epithelial-Mesenchymal Plasticity is regulated by inflammatory signalling networks coupled to cell morphology
    Mar Arias-García, Zheng Yin, Theodoros I. Roumeliotis, Francesca Butera, Lin Wang, Rebecca H. Rickman, Jyoti Sharma Choudhary, Stephen T. C. Wong, Yinyin Yuan, Chris Bakal · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
45. Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor differentiation and therapy
    Qi Ling, Meiching Ong, Björn Konukiewitz, Rüdiger Braun, Jens Uwe Marquardt, Hendrik Lehnert, Holger Kalthoff, Hendrik Ungefroren · 2025 · European Journal of Cancer
46. KDM7 Demethylases: Regulation, Function and Therapeutic Targeting
    Peng Shao, Qi Liu, Hank Heng Qi · 2023 · Advances in experimental medicine and biology
47. RNA modifications in gynecological cancer: current status and future directions
    Wanshan He, Xiaoshan Hong, Guanqiao Chen, Xiping Luo, Yu Lin · 2024 · Frontiers in Medicine
48. The expression and biological function of the PHF2 gene in breast cancer
    Lu Zhang, Tianli Hui, Yuxian Wei, Zhu-Min Cao, Fan Feng, Guo-Sheng Ren, Li Fan · 2018 · RSC Advances
49. Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells
    Alex J. Gooding, William P. Schiemann · 2016 · Translational Cancer Research
50. The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
    Tsung-Cheng Lin, Ying‐Chih Liao, Wen‐Tsan Chang, Cheng-Han Yang, Li-Hsin Cheng, Megan Cheng, Hung-Chi Cheng · 2018 · Journal of Visualized Experiments
51. Identification of Tumor Initiating Cells with a Small‐Molecule Fluorescent Probe by Using Vimentin as a Biomarker
    Yong‐An Lee, Jong‐Jin Kim, Jung Yeol Lee, Jia Hui Jane Lee, Srikanta Sahu, Haw‐Young Kwon, Sung Jin Park, Seyoung Jang, Jun‐Seok Lee, Zhenxun Wang et al. · 2018 · Angewandte Chemie
52. CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
    Shiney Chandraganti, Caitlyn Sams, Sarthak Sahoo, Brian Feng, Isabel O’Connell, Lynna Li, Sunita Nepal, Siddhartha Pulukuri, Kimaya M. Bakhle, Prathapan Thiru et al. · 2026 · Cancer Research Communications
53. Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas
    Matthew Knarr, Jamie Moon, Priyanka Rawat, Analisa V. DiFeo, Dave S.�B. Hoon, Ronny Drapkin · 2024 · Science Signaling
54. Cancer Biology and the Perioperative Period: Opportunities for Disease Evolution and Challenges for Perioperative Care
    Nicholas J. S. Perry, Shaman Jhanji, George Poulogiannis · 2024 · Anesthesia & Analgesia
55. Elucidating the role of EPPK1 in lung adenocarcinoma development
    Ken Arimura, Michael Nolan Kammer, S. M. Jamshedur Rahman, Sheau‐Chiann Chen, Shilin Zhao, Heidi Chen, Rosana Eisenberg, Yong Zou, Sanja Antic, Bradley W. Richmond et al. · 2024 · BMC Cancer
56. Cancer Stem Cells: Concepts, Challenges, and Opportunities for Cancer Therapy
    May Yin Lee, Rajshekhar R. Giraddi, Wai Leong Tam · 2019 · Methods in molecular biology
57. Genomic Instability in Cancer I: DNA-Repair Triggering Primitive Hereditary 4n-Skewed, Amitotic Division-System, the Culprit in EMT/MET/Metaplasia Cancer-Concepts
    Kirsten H. Walen · 2018 · Journal of Cancer Therapy
58. Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression
    Meisam Bagheri, Gadisti Aisha Mohamed, Mohammed Ashick Mohamed Saleem, Mohamed-Ashick M. Saleem, Nevena B. Ognjenovic, Hanxu Lu, Fred Kolling, Owen Michael Wilkins, Subhadeep Das, Ian S. LaCroix et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
59. The Intersection of Epigenetic Alterations and Developmental State in Pediatric Ependymomas
    Alisha Kardian, Stephen C. Mack · 2024 · Developmental Neuroscience
60. Epithelial-mesenchymal dynamics in cancer: Role of signalling pathways, stromal interactions and natural therapies
    Iram Rais Alam Khan, Anindita Behera, Kamesh R. Babu, Faisal Rehman, Farah Rehan, Shraddha Manish Gupta, Siddharth Singh · 2025 · ADMET & DMPK
61. Targeting Phenotypic Plasticity in Prostate Cancer
    Marion Vanneste, Michael D. Henry · 2017 · Current Molecular Biology Reports
62. Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle
    Mengzhu Wang, Zhigang Wang, Bin Qiao, Jin Cao, Luya Quan, Yuanli Luo, Hanwen Qi, Xiaowen Zhong, Yubei He, Xianquan Zhang et al. · 2020 · International Journal of Nanomedicine
63. Breast Cancer Cells Exhibit Mesenchymal–Epithelial Plasticity Following Dynamic Modulation of Matrix Stiffness
    Chinmay S. Sankhe, Jessica L. Sacco, Jacob Lawton, Ryan A. Fair, David Vidotto Rezende Soares, Mohammed K. R. Aldahdooh, Enrique Daniel Gomez, Esther W. Gomez · 2024 · Advanced Biology
64. Targeting tumor resistance mechanisms
    Louise Gerard, Laurent Duvivier, Jean‐Pierre Gillet · 2021 · Faculty Reviews
65. Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
    Ana Filipa Cruz, Nuno André Fonseca, Ana Rita Malheiro, Joana Barbosa Melo, Maria Manuela Gaspar, Rui Fernandes, Vera Moura, Sérgio Simões, João Nuno Moreira · 2022 · European Journal of Pharmaceutics and Biopharmaceutics
66. Human Carcinogenesis: Toward a Unified Theory
    Briana Marshall, Doug Dix · 2017 · OALib
67. Transdifferentiation of goat ear fibroblasts into lactating mammary epithelial cells induced by small molecule compounds
    Dandan Zhang, Yanyan Ren, Liangshan Qin, Quanhui Liu, Guodong Wang, Longfei Sun, Mengmei Li, Deshun Shi, Ben Huang · 2021 · Biochemical and Biophysical Research Communications
68. ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation
    Pan, Guangrui, Huang, Mingquan, Fu, Shaozhi, Wang, Yu, He, Lijia, Wu, Bin, Yang, Jinping, Lin, Sheng, Fan, Yu · 2025 · Scientific Reports
69. Epithelial-Mesenchymal Transition and Tumour Progression: An Overview
    Ismail Ibrahim Al-Janabi · 2023 · Al-Rafidain Journal of Medical Sciences
70. Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells
    Nathalie Mora, Maxence Rosa, Mohamed Touaibia, Luc J. Martin · 2024 · Molecules
71. Near-Dead Cells to Special Tetraploidy to First Cells to Cancer Diagnostic Morphology: Unlikely Therapy-Gain from For-Profit Industrial Goliath
    Kirsten H. Walen · 2020 · Journal of Cancer Therapy
72. Could E-cadherin overexpression promote epithelial differentiation of human adipose-derived stem cells by mediating mesenchymal-to-epithelial transition?
    Zewei Wang, Jingtian Lai, Yu Li, Haiying Zhou, Ahmad Alhaskawi, Pengfei Li, Xinyuan Shen, Hui Lü, Tian Tu · 2023 · Medical Hypotheses
73. Lung endothelium instructs dormancy of susceptible metastatic tumour cells
    Moritz Jakab, Ki Hong Lee, Alexey Uvarovskii, Svetlana Ovchinnikova, Shubhada R. Kulkarni, Till Rostalski, Simon Anders, Hellmut G. Augustin · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
74. Epithelial elements in superficial angiomyxomas: mimicry of adnexal development, and mesenchymal‐to‐epithelial transition
    Carlos Couceiro Monteagudo, Liria Terrádez-Mas, Esther Álvarez, Paloma Masiá, Mónica Espino, María Ortega · 2025 · Histopathology
75. Histone lysine demethylases in breast cancer: molecular mechanisms, biological functions, and therapeutic intervention
    Anqi Wang, Dianjun Qi, Y. Ma, Mozhi Wang, Haoran Dong, Chenxin Wang, Yingfan Zhang, Zheyuan Zhang, Lingwei Li, J H Xu et al. · 2025 · Molecular Cancer
76. Mesenchymal to epithelial transition (MET) in cancer progression: insights from logical modeling
    Sophia Orozco-Ruiz, Marco Ruscone, Emmanuel Barillot, Olivier Destaing, Laurence Calzone · 2026 · Scientific Reports
77. The epithelial-to-mesenchymal transition in cancer: pathogenetic features
    Elizaveta Aleksandrovna Pasechnikova, V. N. Bodnya, Dmitry Vadimovich Kadomtsev, A. Yu. Georgieva, Vladimir A. Porhanov, Шевчук Даниил Дмитриевич · 2022 · Innovative medicine of Kuban
78. Cancer Prevention? Fundamental Genomic Alterations Are Present in Preneoplasia, Including Function of High Frequency Selected Mutations (HFSMs)
    Kirsten H. Walen · 2016 · Journal of Cancer Therapy
79. RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression
    Bin Yi, You Hu, Dongming Zhu, Jun Yao, Jian Zhou, Yi Zhang, Zhilong He, Lifeng Zhang, Zixiang Zhang, Jian Yang et al. · 2022 · Genes & Genomics
80. Enzyme-responsive DNA smart materials for biomedical applications
    Mingxing Liu, Yu Han, Wei Tan, Xiaocui Guo, Chi Yao, Dayong Yang · 2026 · Materials Chemistry Frontiers
81. Intrinsic cellular heterogeneity directs divergent epithelial‐to‐mesenchymal transition outcomes
    Esin Ozkuru Sekeroglu, Seyma Nur Yıldız, Seray Yetkin, Gkamze Impraimoglou Kafaz, Burcu Şengez, Ozlem Erez, Esra Ersoz‐Gulseven, Gulcin Cakan-Akdogan, Tuğçe Batur, Hani Alotaibi · 2026 · FEBS Journal
82. Mesenchymal-epithelial transition supports rapid repair of the endometrial epithelium during postpartum uterine regeneration
    Zidao Wang, Jonathas Medeiros de Almeida, Kimberly M Davenport, Susanta K. Behura, Amanda L. Patterson · 2026 · Communications Biology
83. Clinical Implications of Epithelial-to-Mesenchymal Transition (EMT) in Cancer
    Ludovico Carbone, Giosuè Giordano Incognito, Dalila Incognito, Luigi Marano · 2024 · Interdisciplinary cancer research
84. https://researchopenworld.com/acbd3-its-cellular-interactors-and-its-role-in-breast-cancer/#
    Jack Houghton-Gisby, Amanda Harvey · 2020 · Cancer Studies and Therapeutics
85. Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines
    Barış Küçükkaraduman, Ekin Gokce Cicek, Muhammad Waqas Akbar, Seçil Demirkol Canlı, Burçak Vural, Ali Osmay Gure · 2021 · Molecules
86. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
    Jing Zhang, Midory Thorikay, Gerard van der Zon, Maarten van Dinther, Peter ten Dijke · 2020 · Journal of Visualized Experiments
87. Glutathione Peroxidase 8 (GPX8)-IL6 axis is essential in maintaining breast cancer mesenchymal stem-like state and aggressive phenotype
    Anees Khatib, Balakrishnan Solaimuthu, Michal Ben Yosef, Gidi Oren, Areej Abu Rmaileh, Michal Schlesinger Frisch, Jonathan H. Axelrod, Michal Lichtenstein, Yoav David Shaul · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
88. PDE4 inhibition: a novel therapeutic strategy in liver fibrosis.
    Mohamed Elnagdy · 2021
89. NFYA promotes the malignant behavior of triple-negative breast cancer through the regulation of lipid metabolism
    Nobuhiro Okada, Chihiro Ueki, Masahiro Shimazaki, Goki Tsujimoto, Susumu Kohno, Hayato Muranaka, Kiyotsugu Yoshikawa, Chiaki Takahashi · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
90. Antibody therapy of cancer
    Mandy Gruijs · 2023
91. Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer
    Pradeep S. Chauhan, Irfan Alahi, Savar D. Sinha, Alexander L. Shiang, Ryan Mueller, Jace B. Webster, Ha X. Dang, Debanjan Saha, Lilli J. Greiner, Breanna Yang et al. · 2023 · medRxiv
92. A Coronaviral Pore-Replicase Complex Drives RNA Synthesis in Double Membrane Vesicles
    Anan Chen, Ana‐Mihaela Lupan, Rui Tong Quek, Stefan G. Stanciu, Mihaela Asaftei, George A. Stanciu, Kierra S. Hardy, Taciani de Almeida Magalhães, Pamela A. Silver, Timothy John Mitchison et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
93. The diverse functions of viral microproteins
    Yi Hua Chen, Louisa Grauvogel, Adam S Zhang, André C. Michaelis, Tim Heymann, Elisabeth Zollbrecht, Paulina Engel, Christian Pensl, Kathryn E. Yost, Wesley Suen et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
94. The Interplay of Biomechanics, Tissue Polarity and Collective Migration as it Contributes to Early Heart Organogenesis
    Timothy R. Jackson · 2017 · D-Scholarship@Pitt (University of Pittsburgh)
95. THE ROLES OF CHEMOKINES AND CHEMOKINE RECEPTORS IN TUMOR METASTASIS
    Ahmad Suhail Khazali · 2017 · D-Scholarship@Pitt (University of Pittsburgh)
96. Metastatic cancer: How one can address the therapeutic challenge
    Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal, Ankur Vaidya · 2020 · Elsevier eBooks
97. Defining Epithelial-Mesenchymal Plasticity in Cancer Using Single-Cell Genomics
    David P. Cook · 2021 · uO Research (University of Ottawa)
98. フリーター五右衛門(2)コガネムシの羽音
    昌典 神田 · 2005 · 文蔵
99. Faculty Opinions recommendation of Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
    Avri Ben‐Ze'ev · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
100. Identification and functional characterisation of TGFB: Regulated and cell surface candidates in pancreatic cancer
     James H. Monkman · 2021 · Queensland University of Technology